LATEST ALERTS
Rare cannabinoids that cannot practically be extracted from hemp will instead be manufactured by specially-created micro-organisms.
A new partnership between Cronos Group, a Canadian vertically integrated cannabis company, and Ginkgo Bioworks, a Massachusetts-based bioengineering specialist, will see Ginkgo modify the DNA of yeast so that it can produce cannabinoids in a fermentation process.
They include cannabidiolic acid (CBDA), a substance naturally present in the hemp plant, which is then turned into cannabidiol (CBD) when its chemical composition is altered through heating.
...Are you already a subscriber? login here
